Another mechanism that is independent of RAR/RXR activation and may explain the importance of ALDH1A3 in gliomas and other tumors has been linked to an increased production of NADH that protects the cell from ferroptosis by the activation of ferroptosis suppressor protein 1 (FSP1). The gene discussed is AIFM2; the disease is central nervous system cancer.